Taiwan · Delayed Price · Currency is TWD Synbio Tech Statistics
Total Valuation
Synbio Tech has a market cap or net worth of TWD 3.69 billion. The enterprise value is 4.51 billion.
| Market Cap | 3.69B |
| Enterprise Value | 4.51B |
Important Dates
The next estimated earnings date is Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | Mar 27, 2025 |
Share Statistics
Synbio Tech has 34.48 million shares outstanding. The number of shares has increased by 1.15% in one year.
| Current Share Class | 34.48M |
| Shares Outstanding | 34.48M |
| Shares Change (YoY) | +1.15% |
| Shares Change (QoQ) | +3.77% |
| Owned by Insiders (%) | 22.25% |
| Owned by Institutions (%) | n/a |
| Float | 16.38M |
Valuation Ratios
The trailing PE ratio is 18.85 and the forward PE ratio is 15.55.
| PE Ratio | 18.85 |
| Forward PE | 15.55 |
| PS Ratio | 3.47 |
| PB Ratio | 3.01 |
| P/TBV Ratio | 3.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 16.37 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.75, with an EV/FCF ratio of -16.83.
| EV / Earnings | 25.01 |
| EV / Sales | 4.25 |
| EV / EBITDA | 14.75 |
| EV / EBIT | 19.64 |
| EV / FCF | -16.83 |
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of 1.01.
| Current Ratio | 1.64 |
| Quick Ratio | 1.05 |
| Debt / Equity | 1.01 |
| Debt / EBITDA | 4.03 |
| Debt / FCF | -4.60 |
| Interest Coverage | 88.10 |
Financial Efficiency
Return on equity (ROE) is 16.24% and return on invested capital (ROIC) is 6.66%.
| Return on Equity (ROE) | 16.24% |
| Return on Assets (ROA) | 5.90% |
| Return on Invested Capital (ROIC) | 6.66% |
| Return on Capital Employed (ROCE) | 10.37% |
| Revenue Per Employee | 11.55M |
| Profits Per Employee | 1.96M |
| Employee Count | 92 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 2.34 |
Taxes
In the past 12 months, Synbio Tech has paid 41.47 million in taxes.
| Income Tax | 41.47M |
| Effective Tax Rate | 18.69% |
Stock Price Statistics
The stock price has increased by +25.88% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +25.88% |
| 50-Day Moving Average | 125.43 |
| 200-Day Moving Average | 98.18 |
| Relative Strength Index (RSI) | 37.78 |
| Average Volume (20 Days) | 475,906 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Synbio Tech had revenue of TWD 1.06 billion and earned 180.49 million in profits. Earnings per share was 5.68.
| Revenue | 1.06B |
| Gross Profit | 578.87M |
| Operating Income | 229.84M |
| Pretax Income | 221.96M |
| Net Income | 180.49M |
| EBITDA | 302.61M |
| EBIT | 229.84M |
| Earnings Per Share (EPS) | 5.68 |
Balance Sheet
The company has 408.76 million in cash and 1.23 billion in debt, giving a net cash position of -825.66 million or -23.95 per share.
| Cash & Cash Equivalents | 408.76M |
| Total Debt | 1.23B |
| Net Cash | -825.66M |
| Net Cash Per Share | -23.95 |
| Equity (Book Value) | 1.22B |
| Book Value Per Share | 35.51 |
| Working Capital | 344.78M |
Cash Flow
In the last 12 months, operating cash flow was 225.35 million and capital expenditures -493.67 million, giving a free cash flow of -268.32 million.
| Operating Cash Flow | 225.35M |
| Capital Expenditures | -493.67M |
| Free Cash Flow | -268.32M |
| FCF Per Share | -7.78 |
Margins
Gross margin is 54.47%, with operating and profit margins of 21.63% and 16.98%.
| Gross Margin | 54.47% |
| Operating Margin | 21.63% |
| Pretax Margin | 20.89% |
| Profit Margin | 16.98% |
| EBITDA Margin | 28.48% |
| EBIT Margin | 21.63% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 3.27%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 3.27% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 86.35% |
| Buyback Yield | -1.15% |
| Shareholder Yield | 2.13% |
| Earnings Yield | 4.89% |
| FCF Yield | -7.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 6, 2024. It was a forward split with a ratio of 1.02.
| Last Split Date | Aug 6, 2024 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Synbio Tech has an Altman Z-Score of 2.05 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.05 |
| Piotroski F-Score | 5 |